| Literature DB >> 25306156 |
James D Lee, Ponnusamy Saravanan1, Lakshminarayanan Varadhan, John R Morrissey, Vinod Patel.
Abstract
BACKGROUND: The Alphabet Strategy (AS) is a diabetes care checklist ensuring "important, simple things are done right all the time." Current audits of diabetes care in developed countries reveal wide variations in quality with performance of care processes frequently sub-optimal. This study had three components:• an audit to assess diabetes care quality worldwide,• a questionnaire study seeking opinions on the merits of the AS,• a pilot study to assess the practicality of implementation of the AS in a low socioeconomic setting.Entities:
Mesh:
Year: 2014 PMID: 25306156 PMCID: PMC4283094 DOI: 10.1186/1472-6963-14-467
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
QOF targets and maximum points achievable (2004), with format adapted to domains of the Alphabet Strategy
| Quality Indicator | Maximum points† | ||
|---|---|---|---|
| General | 1 | General background data: register of all diabetes mellitus patients | 6 |
| Advice | 2 | % whose notes record diabetes mellitus | 3 |
| 3 | % with record of smoking status | 3 | |
| 4 | % who smoke and a record that smoking cessation advice has been offered | 3 | |
| 18 | % who have had influenza immunisation in the preceding 1 Sep to 31 Mar | 5 | |
| Blood pressure | 11 | % with a record of blood pressure | 3 |
| 12 | % whose last blood pressure is 145/85 or less | 17 | |
| Cholesterol & creatinine | 16 | % who have a record of total cholesterol | 3 |
| 17 | % whose last total cholesterol is 5 or less | 6 | |
| 13 | % with a record of microalbuminuria testing | 3 | |
| 14 | % with a record of serum creatinine testing | 3 | |
| Diabetes control | 5 | % who have a record of HbA1c | 3 |
| 6 | % with HbA1c of 7.4 or less | 16 | |
| 7 | % with HbA1c of 10 or less | 11 | |
| Eyes | 8 | % who have a record of retinal screening | 5 |
| Feet | 9 | % with a record of presence or absence of peripheral pulses | 3 |
| 10 | % with a record of neuropathy testing | 3 | |
| Guardian drugs | 15 | % with proteinuria or microalbuminuria who are treated with ACE inhibitor (or ARB) | 3 |
| Total points | 99 | ||
The numbers in this column denotes the quality indicator in the original QOF Quality Indicator list.
†Points are given from a specific lower threshold towards a higher threshold.
QOF scores of centres with corresponding GNI, GDP, THE%, and LE
| Serial number | Country | QOF score (out of 99) | GNI per capita 2005/06*† | GDP per capita/US$* | THE%* | LE/years* |
|---|---|---|---|---|---|---|
| GRE2 | Greece | 90.14 | H | 23506 | 9.7 | 79 |
| JER | Jersey | 87.52 | H | 57000 | 8.1 | 80 |
| FRA1 | France | 85.02 | H | 33819 | 11.1 | 80 |
| SPA2 | Spain | 81.65 | H | 28025 | 8.3 | 81 |
| IND10 | India | 80.56 | LM | 820 | 4.0 | 64 |
| ENG | England | 78.95 | H | 40342 | 8.5 | 79 |
| FAL | Falklands | 78.92 | H | 40342 | 8.5 | 79 |
| FRA2 | France | 77.19 | H | 35457 | 11.1 | 81 |
| AUS3 | Australia | 76.93 | H | 34149 | 8.4 | 81 |
| NOR | Norway | 76.54 | H | 65767 | 9.1 | 80 |
| SPA | Spain | 72.44 | H | 26056 | 8.3 | 80 |
| AUS4 | Australia | 72.08 | H | 34149 | 8.4 | 81 |
| AUS2 | Australia | 68.30 | H | 34149 | 8.4 | 81 |
| GRE1 | Greece | 68.12 | H | 21621 | 9.6 | 79 |
| IND1 | India | 66.79 | LM | 732 | 4.0 | 63 |
| USA | USA | 66.40 | H | 42516 | 14.7 | 77 |
| SAF1 | South Africa | 59.05 | UM | 5235 | 8.8 | 51 |
| BAR | Barbados | 54.46 | H | 11109 | 7.0 | 76 |
| IND8 | India | 53.48 | LM | 820 | 4.0 | 64 |
| IND7 | India | 50.74 | LM | 820 | 4.0 | 64 |
| MAL | Malaysia | 48.31 | H | 5286 | 4.1 | 73 |
| IRE | Ireland | 45.69 | H | 48866 | 7.5 | 78 |
| JAM | Jamaica | 41.29 | UM | 4263 | 4.1 | 71 |
| GUY | Guyana | 37.74 | LM | 1949 | 6.0 | 68 |
| WSA | Western Samoa | 37.21 | UM | 2287 | 5.5 | 71 |
| IND9 | India | 36.59 | LM | 5468 | 8.5 | 64 |
| SAF2 | South Africa | 36.59 | UM | 820 | 4.0 | 51 |
| IND5 | India | 36.16 | LM | 732 | 4.0 | 63 |
| BAN | Bangladesh | 35.71 | LM | 429 | 3.2 | 67 |
| ZIM | Zimbabwe | 35.12 | L | 434 | 8.1 | 45 |
| IND3 | India | 33.91 | LM | 732 | 4.0 | 63 |
| STK | St. Kitts | 32.75 | H | 10394 | 5.4 | 71 |
| GHA | Ghana | 32.42 | LM | 495 | 7.1 | 61 |
| PER | Peru | 31.66 | UM | 3312 | 4.5 | 73 |
| MAU | Mauritius | 30.05 | UM | 5054 | 4.6 | 72 |
| GRN | Grenada | 29.26 | UM | 6804 | 6.4 | 75 |
| IND4 | India | 29.20 | LM | 732 | 4.0 | 63 |
| IND2 | India | 27.11 | LM | 732 | 4.0 | 63 |
| SOL | Solomon Islands | 25.26 | LM | 881 | 4.6 | 65 |
| GHA2 | Ghana | 19.70 | LM | 495 | 7.1 | 61 |
| AUS1 | Australia | 19.66 | H | 34149 | 8.4 | 81 |
| IND6 | India | 17.27 | LM | 732 | 4.0 | 63 |
| EGY | Egypt | 16.16 | UM | 1209 | 5.2 | 72 |
| BEL | Belize | 13.35 | UM | 3821 | 3.5 | 75 |
| TON | Tonga | 10.16 | UM | 2573 | 4.7 | 71 |
*Gross National Income (GNI) per capita, Gross Domestic Product (GDP), Total Health Expenditure percentage per capita (THE%) and life expectancy from birth (LE) taken from data.worldbank.org for years 2005/2006.
†H: High income country; UM: upper middle; LM: lower middle; L: low.
Recording of NICE nine key processes of care/% of centre cohort
| Serial no. | Country | QOF score | NICE 9 | BMI* | Smoking* | BP* | TC* | Cr* | Microalb* | Urine prot* | HbA1c* | Eye* exam | Foot* exam |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GRE2 | Greece | 90.14 | 60 |
|
|
|
|
|
|
|
|
|
|
| JER | Jersey | 87.52 | 74 |
|
|
|
|
|
| 54 |
|
|
|
| FRA1 | France | 85.02 | 47 |
|
|
|
|
|
| 46 |
|
|
|
| SPA2 | Spain | 81.65 | 6 |
| 8 |
|
|
| 61 | 6 |
|
|
|
| IND10 | India | 80.56 | 0 |
|
|
|
| 49 | 0 |
| 0 |
|
|
| ENG | England | 78.95 | 3 | 60 |
|
|
|
| 10 | 4 |
| 69 |
|
| FAL | Falklands | 78.92 | 0 |
|
|
|
| 10 |
|
|
| 6 | 36 |
| FRA2 | France | 77.19 | 63 |
|
|
|
|
| 59 |
|
|
|
|
| AUS3 | Australia | 76.93 | 0 | 0 |
|
|
|
| 68 | 18 |
|
|
|
| NOR | Norway | 76.54 | 26 | 56 | 59 |
|
|
|
| 61 |
|
|
|
| SPA1 | Spain | 72.44 | 16 |
| 66 |
|
|
| 62 | 28 |
| 55 | 41 |
| AUS4 | Australia | 72.08 | 0 | 20 | 40 |
|
|
| 1 | 0 |
|
|
|
| AUS2 | Australia | 68.30 | 4 | 31 | 35 |
|
| 66 | 20 | 2 |
| 55 | 54 |
| GRE1 | Greece | 68.12 | 26 |
| 45 |
|
|
|
|
|
|
|
|
| IND1 | India | 66.79 | 37 |
| 38 |
|
|
|
|
|
|
|
|
| USA | USA | 66.40 | 5 |
| 37 |
| 37 |
| 67 | 13 |
|
| 68 |
| SAF1 | South Africa | 59.05 | 39 | 61 | 68 |
|
|
|
| 37 |
|
|
|
| BAR | Barbados | 54.46 | 0 | 68 |
|
|
| 7 | 0 | 17 |
|
|
|
| IND8 | India | 53.48 | 0 | 45 | 6 |
|
|
| 46 |
| 57 |
|
|
| IND7 | India | 50.74 | 1 |
| 46 |
| 22 |
| 0 |
| 2 |
|
|
| MAL | Malaysia | 48.31 | 2 | 26 | 51 |
|
|
| 19 | 59 | 61 | 65 | 66 |
| IRE | Ireland | 45.69 | 5 | 33 | 38 |
|
|
|
| 0 |
|
| 27 |
| JAM | Jamaica | 41.29 | 1 | 56 | 6 |
| 62 | 55 | 60 | 57 | 56 | 56 | 51 |
| GUY | Guyana | 37.74 | 0 | 0 | 5 |
| 31 | 42 | 1 | 5 | 0 | 0 | 0 |
| WSA | Western Samoa | 37.21 | 0 | 0 | 39 |
| 39 | 49 | 0 | 35 | 26 | 56 | 52 |
| IND9 | South Africa | 36.59 | 0 | 10 |
|
| 40 |
| 10 | 9 | 51 | 40 | 63 |
| SAF2 | India | 36.59 | 0 | 43 |
|
| 38 | 57 | 32 | 0 | 3 | 10 | 51 |
| IND5 | India | 36.16 | 0 | 1 | 50 |
|
|
| 7 | 47 | 23 | 23 | 4 |
| BAN | Bangladesh | 35.71 | 0 |
|
|
| 10 | 14 | 65 | 3 | 8 | 0 | 0 |
| ZIM | Zimbabwe | 35.16 | 0 |
| 2 |
| 0 | 0 | 0 | 42 | 1 | 48 | 22 |
| IND3 | India | 33.91 | 0 | 4 | 50 |
| 48 |
| 0 | 54 | 8 | 4 | 12 |
| STK | St. Kitts | 32.75 | 0 | 2 | 0 |
|
| 49 | 2 | 49 | 0 | 1 | 2 |
| GHA | Ghana | 32.42 | 0 |
|
|
| 5 | 21 | 2 | 6 | 1 | 22 | 8 |
| PER | Peru | 31.66 | 0 | 64 | 0 |
| 50 | 34 | 1 | 9 | 3 | 1 | 1 |
| MAU | Mauritius | 30.05 | 0 | 2 | 28 |
| 5 |
| 5 | 1 | 1 | 18 | 14 |
| GRN | Grenada | 29.26 | 0 | 1 |
|
| 19 |
| 10 | 6 | 0 | 13 | 3 |
| IND4 | India | 29.20 | 0 |
|
|
|
| 27 | 1 | 0 | 6 |
| 69 |
| IND2 | India | 27.11 | 0 | 0 | 0 |
| 0 | 49 | 4 | 4 | 0 | 4 | 2 |
| SOL | Solomon Is | 25.26 | 0 | 8 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| GHA2 | Ghana | 19.70 | 0 | 0 | 0 |
| 59 | 43 | 1 |
| 37 | 54 | 60 |
| AUS1 | Australia | 19.66 | 0 | 60 |
| 17 | 48 | 39 | 18 | 0 | 47 | 29 | 41 |
| IND6 | India | 17.27 | 0 | 0 | 3 |
| 13 | 19 | 20 | 15 | 0 | 1 | 0 |
| EGY | Egypt | 16.16 | 0 | 0 | 25 |
| 3 | 30 | 0 | 3 | 0 | 3 | 17 |
| BEL | Belize | 13.35 | 0 | 0 | 2 |
| 42 | 40 | 0 | 20 | 0 | 2 | 10 |
| TON | Tonga | 10.16 | 0 | 26 | 44 |
| 6 | 20 | 0 | 0 | 0 | 0 | 46 |
*Bold font >90; Italic font 70–89; Normal font <70.
Results of correlation of individual NICE9 components versus THE% using fisher transformation
| NICE9 care process assessment | Correlated? | Correlation coefficient | z statistic | p value |
|---|---|---|---|---|
|
| Yes | 0.357 | 2.421 | 0.015 |
|
| No | 0.282 | 1.877 | 0.061 |
|
| No | -0.081 | 0.528 | 0.598 |
|
| Yes | 0.376 | 2.564 | 0.01 |
|
| Yes | 0.343 | 2.314 | 0.021 |
|
| Yes | 0.493 | 3.496 | <0.001 |
|
| No | 0.069 | 0.448 | 0.654 |
|
| Yes | 0.713 | 5.789 | <0.001 |
|
| Yes | 0.491 | 3.484 | <0.001 |
|
| Yes | 0.453 | 3.166 | 0.002 |
Results of questions 1–9 using VAS format
| Question | Total complete answers | Mean | Median | Mode | Interquartile range | Min range | Max range | % response >50 | |
|---|---|---|---|---|---|---|---|---|---|
|
|
| 203 | 83 | 87 | 100 | 77-96 | 2 | 100 | 93 |
|
|
| 192 | 69 | 80 | 100 | 48-92 | 0 | 100 | 71 |
|
|
| 199 | 73 | 82 | 100 | 56-93 | 0 | 100 | 79 |
|
|
| 191 | 77 | 82 | 100 | 64-95 | 0 | 100 | 85 |
|
|
| 199 | 57 | 60 | 100 | 33-88 | 0 | 100 | 56 |
|
|
| 195 | 78 | 91 | 100 | 78-98 | 0 | 100 | 84 |
|
|
| 195 | 42 | 40 | 0 | 5-79 | 0 | 100 | 36 |
|
|
| 201 | 83 | 87 | 100 | 76-97 | 5 | 100 | 92 |
Figure 1Graphical representation of response to questions 1–9 on VAS. Black ≤50; Grey >50.
Responses to questions 10 and 11
| Question | Yes | No | Total respondents | % respondents answering yes | |
|---|---|---|---|---|---|
|
| Do you think this strategy is practical? | 179 | 18 | 197 | 91% |
|
| Do you think this strategy is evidence based? | 176 | 4 | 180 | 98% |
Figure 2Responses for question 12 (“Which healthcare professional should adopt the strategy?”).
Changes to performance and documentation of diabetes care process following implementation of the alphabet strategy in India
| Care process recording | % Before implementation | % After implementation | p value | |
|---|---|---|---|---|
|
| Body Mass Index | 99 | 99 | NS |
| Smoking status | 99 | 99 | NS | |
| Smoking cessation | 100 | 100 | NS | |
|
| Blood pressure | 99 | 99 | NS |
|
| Total cholesterol | 60 | 99 | <0.001 |
| Lipid profile | 10 | 64 | <0.001 | |
| Creatinine | 5 | 49 | <0.001 | |
| Proteinuria | 48 | 93 | <0.001 | |
|
| Fasting and postprandial glucose | 41 | 97 | <0.001 |
|
| Eye examination | 98 | 100 | NS |
|
| Feet examination | 95 | 100 | NS |
|
| Aspirin therapy | 6 | 71 | <0.001 |
| ACEI/ARB therapy | 7 | 57 | <0.001 | |
| Statin therapy | 5 | 38 | <0.001 | |
| Aspirin + ACEI/ARB + Statin | 2 | 20 | <0.001 | |
|
| 45 | 61 | <0.001 | |